Position in AMGN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$2,256,731
-$83,070 QoQ
Shares Held
6,232
-6.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,215
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SIGNATURE ESTATE & INVESTMENT ADVISORS LLC holds $78,743,107 across 9 Drug Manufacturers - General names. AMGN ranks #3 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
57,559 | $69,037,996 | |
| 2 | JNJ |
Johnson & Johnson
|
8,972 | $2,278,618 | |
| 3 | AMGN |
Amgen Inc
This page
|
6,232 | $2,256,731 | |
| 4 | ABBV |
AbbVie Inc.
|
5,312 | $1,336,711 | |
| 5 | AZN |
Astrazeneca PLC
|
6,802 | $1,289,794 | |
| 6 | PFE |
Pfizer Inc
|
38,803 | $934,375 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,229 | $928,926 | |
| 8 | NVO |
Novo Nordisk A S
|
8,810 | $422,350 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,256,731 | 6,232 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $2,339,801 | 6,650 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $2,081,691 | 6,360 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,766,571 | 6,260 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,735,568 | 6,216 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,737,202 | 5,576 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $965,409 | 3,704 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,187,987 | 3,687 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,138,879 | 3,645 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $786,713 | 2,767 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $860,603 | 2,988 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $742,314 | 2,762 | Shares | Defined | 2023-10-26 | |
| 2023-06-30 | $613,218 | 2,762 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $660,944 | 2,734 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $718,057 | 2,734 | Shares | Defined | 2023-01-11 | |
| 2022-09-30 | $617,370 | 2,739 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $667,614 | 2,744 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $662,828 | 2,741 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $597,294 | 2,655 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $588,615 | 2,768 | Shares | Defined | 2021-10-12 | |
| 2021-06-30 | $647,156 | 2,655 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $1,059,929 | 4,260 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $1,209,378 | 5,260 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $1,092,887 | 4,300 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,052,643 | 4,463 | Shares | Defined | 2020-07-21 | |
| 2020-03-31 | $899,107 | 4,435 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||